BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21673707)

  • 1. The search for a chemoprevention agent effective against melanoma: considerations and challenges.
    Ming ME
    J Invest Dermatol; 2011 Jul; 131(7):1401-3. PubMed ID: 21673707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do nonsteroidal anti-inflammatory drugs prevent melanoma?
    Bard S; Kirsner RS
    J Invest Dermatol; 2011 Jul; 131(7):1394. PubMed ID: 21673704
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study.
    Curiel-Lewandrowski C; Nijsten T; Gomez ML; Hollestein LM; Atkins MB; Stern RS
    J Invest Dermatol; 2011 Jul; 131(7):1460-8. PubMed ID: 21390049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of skin melanoma: facts and myths.
    Uzarska M; Czajkowski R; Schwartz RA; Bajek A; Zegarska B; Drewa T
    Melanoma Res; 2013 Dec; 23(6):426-33. PubMed ID: 24077511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin use and melanoma risk: a review of the literature.
    Famenini S; Young LC
    J Am Acad Dermatol; 2014 Jan; 70(1):187-91. PubMed ID: 24355265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin and other NSAIDs as chemoprevention agents in melanoma.
    Goodman JR; Grossman D
    Cancer Prev Res (Phila); 2014 Jun; 7(6):557-64. PubMed ID: 24694780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin as a chemopreventive agent for cutaneous melanoma: a literature review.
    Pulumati A; Algarin YA; Jaalouk D; Kim S; Latta S; Nouri K
    Arch Dermatol Res; 2024 Jun; 316(7):367. PubMed ID: 38850411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-steroidal anti-inflammatory drugs in cancer prevention and therapy.
    Guadagni F; Ferroni P; Palmirotta R; Del Monte G; Formica V; Roselli M
    Anticancer Res; 2007; 27(5A):3147-62. PubMed ID: 17970056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What about chemoprevention for melanoma?
    Demierre MF
    Curr Opin Oncol; 2006 Mar; 18(2):180-4. PubMed ID: 16462188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma chemoprevention.
    Francis SO; Mahlberg MJ; Johnson KR; Ming ME; Dellavalle RP
    J Am Acad Dermatol; 2006 Nov; 55(5):849-61. PubMed ID: 17052492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma Chemoprevention: Current Status and Future Prospects.
    Chhabra G; Ndiaye MA; Garcia-Peterson LM; Ahmad N
    Photochem Photobiol; 2017 Jul; 93(4):975-989. PubMed ID: 28295364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study.
    Johannesdottir SA; Chang ET; Mehnert F; Schmidt M; Olesen AB; Sørensen HT
    Cancer; 2012 Oct; 118(19):4768-76. PubMed ID: 22644960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemopreventive activities of etodolac and oxyphenbutazone against mouse skin carcinogenesis.
    Kapadia GJ; Azuine MA; Shigeta Y; Suzuki N; Tokuda H
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2546-8. PubMed ID: 20299217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of melanoma: theoretical and practical considerations.
    Demierre MF; Sondak VK
    Cancer Control; 2005 Oct; 12(4):219-22. PubMed ID: 16258492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
    Williams JL; Borgo S; Hasan I; Castillo E; Traganos F; Rigas B
    Cancer Res; 2001 Apr; 61(8):3285-9. PubMed ID: 11309281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse association of non-steroidal anti-inflammatory drugs and malignant melanoma among women.
    Harris RE; Beebe-Donk J; Namboodiri KK
    Oncol Rep; 2001; 8(3):655-7. PubMed ID: 11295097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms in tumor promotion: guidance for risk assessment and cancer chemoprevention.
    Marks F; Fürstenberger G; Heinzelmann T; Müller-Decker K
    Toxicol Lett; 1995 Dec; 82-83():907-17. PubMed ID: 8597161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.
    Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ
    Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of aspirin and non-aspirin NSAIDs in preventing melanoma.
    Ally MS; Swetter SM; Tang JY
    Future Oncol; 2013 Nov; 9(11):1671-4. PubMed ID: 23731359
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemoprevention of skin cancer and photoaging.
    Uliasz A; Spencer JM
    Clin Dermatol; 2004; 22(3):178-82. PubMed ID: 15262302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.